Adriano Gravina
0000-0002-5675-8457
Istituto Nazionale Tumori IRCCS Fondazione Pascale
2 papers found
Refreshing results…
Efficacy of adjuvant chemotherapy schedules for breast cancer according to body mass index: results from the phase III GIM2 trial.
Safety, Efficacy, and Biomarker Analyses of Dostarlimab in Patients with Endometrial Cancer: Interim Results of the Phase I GARNET Study
Missing publications? Search for publications with a matching author name.